Director/PDMR Shareholding

RNS Number : 6540T
Genus PLC
15 November 2019
 

15 November 2019

 

Genus plc

 

Director/PDMR Shareholding

 

Genus plc (LSE: GNS) announces that, further to the vesting of conditional nil-cost options on 14 September 2019 under the Genus Deferred Share Bonus Plan (the 'DSBP') as listed in table A below, members of the Genus Executive Leadership Team ('GELT') sold ordinary shares in Genus on 14 November 2019 and 15 November 2019 respectively, on the London Stock Exchange, to offset income tax and social security liabilities due on the exercises and retained the balance of ordinary shares. 

 

The below notifications, made in accordance with the requirements of the EU Market Abuse Regulation, gives further detail of the number of nil-cost options exercised and ordinary shares sold on 14 November 2019 and 15 November 2019 respectively.

 

For further information please contact:

 

Genus:

Vaughn Walton, Deputy Company Secretary                                                                       Tel: +44 (0)1256 347100

 

Table A - GELT Deferred Share Bonus Plan Exercises  

1.   

Details of the person discharging managerial responsibilities / person closely associated

a.            

Name

1.    Stephen Wilson

2.    Dan Hartley

3.    William Christianson

4.    Jerry Thompson

2.             

Reason for the notification

a.             

Position/status

1.    Chief Executive Officer

2.    Group General Counsel & Company Secretary

3.    Chief Operating Officer Genus PIC

4.    Chief Operating Officer Genus ABS Beef

b.             

Initial notification

/Amendment

Initial notification

3.             

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a.             

Name

Genus plc

b.             

LEI

54930022EOITNKSIGH56

4.             

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.             

Description of the

Financial instrument, type of instrument

Identification code

Ordinary shares of 10p each

 

 

GB0002074580

b.             

Nature of the transaction

Exercise of nil-cost options under the DSBP.

c.             

Price(s) and volume(s)

 

Price(s)

Volume(s)

1.  0.00p

2.  0.00p

3.  0.00p

4.  0.00p

4,725

2,474

2,880

2,426

d.             

Aggregated information

·    Aggregated volume

·    Price

 

 

Average price(s)

Total volume(s)

1.  0.00p

2.  0.00p

3.  0.00p

4.  0.00p

4,725

2,474

2,880

2,426

e.             

Date of the transaction

1.  2019-11-14

2.  2019-11-14

3.  2019-11-15

4.  2019-11-15

f.             

Place of the transaction

Outside a trading venue.

5.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.

 

Description of the

Financial instrument, type of instrument

Identification code

Ordinary shares of 10p each

 

 

GB0002074580

b.

Nature of the transaction

Sale of shares arising from the exercise of nil-cost options under the DSBP to offset income tax and social security liabilities due on the exercise.

c.

Price(s) and volume(s)

 

Price(s)

 

Volume(s)

1.  3,126.00p

2.  3,109.56p

3.  3,064.00p

4.  3,054.00p

2,274

1,191

1,175

965

d.

Aggregated information

·    Aggregated volume

·    Price

 

 

Price(s)

 

Volume(s)

1.  3,126.00p

2.  3,109.56p

3.  3,064.00p

4.  3,054.00p

2,274

1,191

1,175

965

e.

Date of the transaction

1.  2019-11-14

2.  2019-11-14

3.  2019-11-15

4.  2019-11-15

f.

Place of the transaction

London Stock Exchange, Main Market (XLON)

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHUVAWRKNAAAAA

Companies

Genus (GNS)
UK 100

Latest directors dealings